
### [MONDO:0008315](http://purl.obolibrary.org/obo/MONDO_0008315)
**Label:** prostate cancer

**Subclasses:** [MONDO:0013872](http://purl.obolibrary.org/obo/MONDO_0013872) (prostate cancer, hereditary, 2), [MONDO:0011270](http://purl.obolibrary.org/obo/MONDO_0011270) (prostate cancer, hereditary, 8), [MONDO:0012300](http://purl.obolibrary.org/obo/MONDO_0012300) (prostate cancer, hereditary, 6), [MONDO:0012244](http://purl.obolibrary.org/obo/MONDO_0012244) (prostate cancer, hereditary, 5), [MONDO:0011098](http://purl.obolibrary.org/obo/MONDO_0011098) (prostate cancer, hereditary, 1), [MONDO:0002834](http://purl.obolibrary.org/obo/MONDO_0002834) (primary prostate urothelial carcinoma), [MONDO:0000993](http://purl.obolibrary.org/obo/MONDO_0000993) (prostate squamous cell carcinoma), [MONDO:0000994](http://purl.obolibrary.org/obo/MONDO_0000994) (malignant prostate phyllodes tumor), [MONDO:0004956](http://purl.obolibrary.org/obo/MONDO_0004956) (metastatic prostate cancer), [MONDO:0000996](http://purl.obolibrary.org/obo/MONDO_0000996) (prostate lymphoma), [MONDO:0002854](http://purl.obolibrary.org/obo/MONDO_0002854) (prostate sarcoma), [MONDO:0002574](http://purl.obolibrary.org/obo/MONDO_0002574) (prostate embryonal rhabdomyosarcoma), [MONDO:0002672](http://purl.obolibrary.org/obo/MONDO_0002672) (prostate signet ring cell adenocarcinoma), [MONDO:0003368](http://purl.obolibrary.org/obo/MONDO_0003368) (prostate leiomyosarcoma), [MONDO:0002493](http://purl.obolibrary.org/obo/MONDO_0002493) (prostatic acinar adenocarcinoma), [MONDO:0012620](http://purl.obolibrary.org/obo/MONDO_0012620) (HPC10), [MONDO:0012741](http://purl.obolibrary.org/obo/MONDO_0012741) (prostate cancer, hereditary, 12), [MONDO:0005082](http://purl.obolibrary.org/obo/MONDO_0005082) (prostate adenocarcinoma), [MONDO:0010405](http://purl.obolibrary.org/obo/MONDO_0010405) (HPCX2), [MONDO:0012769](http://purl.obolibrary.org/obo/MONDO_0012769) (HPC14), [MONDO:0006390](http://purl.obolibrary.org/obo/MONDO_0006390) (prostate small cell carcinoma), [MONDO:0012768](http://purl.obolibrary.org/obo/MONDO_0012768) (HPC11), [MONDO:0011361](http://purl.obolibrary.org/obo/MONDO_0011361) (prostate cancer/brain Cancer susceptibility), [MONDO:0012470](http://purl.obolibrary.org/obo/MONDO_0012470) (HPC7), [MONDO:0012597](http://purl.obolibrary.org/obo/MONDO_0012597) (prostate cancer, hereditary, 9), [MONDO:0012770](http://purl.obolibrary.org/obo/MONDO_0012770) (HPC15), [MONDO:0003558](http://purl.obolibrary.org/obo/MONDO_0003558) (adenosquamous prostate carcinoma), [MONDO:0012094](http://purl.obolibrary.org/obo/MONDO_0012094) (prostate cancer, hereditary, 4), [MONDO:0002743](http://purl.obolibrary.org/obo/MONDO_0002743) (prostate colloid adenocarcinoma), [MONDO:0012093](http://purl.obolibrary.org/obo/MONDO_0012093) (prostate cancer, hereditary, 3), [MONDO:0004623](http://purl.obolibrary.org/obo/MONDO_0004623) (prostate carcinoma in situ), [MONDO:0004124](http://purl.obolibrary.org/obo/MONDO_0004124) (prostate stromal sarcoma), [MONDO:0005159](http://purl.obolibrary.org/obo/MONDO_0005159) (prostate carcinoma), [MONDO:0006389](http://purl.obolibrary.org/obo/MONDO_0006389) (prostate rhabdomyosarcoma), [MONDO:0003177](http://purl.obolibrary.org/obo/MONDO_0003177) (prostate adenoid cystic carcinoma), [MONDO:0004164](http://purl.obolibrary.org/obo/MONDO_0004164) (lymphoepithelioma-like acinar prostate adenocarcinoma), [MONDO:0003790](http://purl.obolibrary.org/obo/MONDO_0003790) (prostatic urethra urothelial carcinoma), [MONDO:0006067](http://purl.obolibrary.org/obo/MONDO_0006067) (acinar prostate mucinous adenocarcinoma), [MONDO:0003033](http://purl.obolibrary.org/obo/MONDO_0003033) (prostate angiosarcoma), [MONDO:0006066](http://purl.obolibrary.org/obo/MONDO_0006066) (acinar prostate adenocarcinoma, foamy gland variant), [MONDO:0010257](http://purl.obolibrary.org/obo/MONDO_0010257) (HPCX1), [MONDO:0012758](http://purl.obolibrary.org/obo/MONDO_0012758) (prostate cancer, hereditary, 13), 

**Mapped go classes:** [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0021952](http://purl.obolibrary.org/obo/GO_0021952) (central nervous system projection neuron axonogenesis), [GO:0004540](http://purl.obolibrary.org/obo/GO_0004540) (ribonuclease activity), [GO:0007413](http://purl.obolibrary.org/obo/GO_0007413) (axonal fasciculation), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0042780](http://purl.obolibrary.org/obo/GO_0042780) (tRNA 3'-end processing), [GO:0031915](http://purl.obolibrary.org/obo/GO_0031915) (positive regulation of synaptic plasticity), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0000902](http://purl.obolibrary.org/obo/GO_0000902) (cell morphogenesis), [GO:0042781](http://purl.obolibrary.org/obo/GO_0042781) (3'-tRNA processing endoribonuclease activity), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0005003](http://purl.obolibrary.org/obo/GO_0005003) (ephrin receptor activity), [GO:0060996](http://purl.obolibrary.org/obo/GO_0060996) (dendritic spine development), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0060997](http://purl.obolibrary.org/obo/GO_0060997) (dendritic spine morphogenesis), [GO:0005005](http://purl.obolibrary.org/obo/GO_0005005) (transmembrane-ephrin receptor activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0004549](http://purl.obolibrary.org/obo/GO_0004549) (tRNA-specific ribonuclease activity), [GO:0099557](http://purl.obolibrary.org/obo/GO_0099557) (trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0016363](http://purl.obolibrary.org/obo/GO_0016363) (nuclear matrix), [GO:1900273](http://purl.obolibrary.org/obo/GO_1900273) (positive regulation of long-term synaptic potentiation), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0043488](http://purl.obolibrary.org/obo/GO_0043488) (regulation of mRNA stability), [GO:0008046](http://purl.obolibrary.org/obo/GO_0008046) (axon guidance receptor activity), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0060026](http://purl.obolibrary.org/obo/GO_0060026) (convergent extension), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0051389](http://purl.obolibrary.org/obo/GO_0051389) (inactivation of MAPKK activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0071679](http://purl.obolibrary.org/obo/GO_0071679) (commissural neuron axon guidance), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0006397](http://purl.obolibrary.org/obo/GO_0006397) (mRNA processing), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0001540](http://purl.obolibrary.org/obo/GO_0001540) (amyloid-beta binding), [GO:0001655](http://purl.obolibrary.org/obo/GO_0001655) (urogenital system development), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001933](http://purl.obolibrary.org/obo/GO_0001933) (negative regulation of protein phosphorylation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0043021](http://purl.obolibrary.org/obo/GO_0043021) (ribonucleoprotein complex binding), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0006364](http://purl.obolibrary.org/obo/GO_0006364) (rRNA processing), [GO:0045444](http://purl.obolibrary.org/obo/GO_0045444) (fat cell differentiation), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0007612](http://purl.obolibrary.org/obo/GO_0007612) (learning), [GO:0044877](http://purl.obolibrary.org/obo/GO_0044877) (macromolecular complex binding), [GO:0007611](http://purl.obolibrary.org/obo/GO_0007611) (learning or memory), [GO:0021631](http://purl.obolibrary.org/obo/GO_0021631) (optic nerve morphogenesis), [GO:0048168](http://purl.obolibrary.org/obo/GO_0048168) (regulation of neuronal synaptic plasticity), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0050878](http://purl.obolibrary.org/obo/GO_0050878) (regulation of body fluid levels), [GO:0019843](http://purl.obolibrary.org/obo/GO_0019843) (rRNA binding), [GO:0051965](http://purl.obolibrary.org/obo/GO_0051965) (positive regulation of synapse assembly), [GO:1904782](http://purl.obolibrary.org/obo/GO_1904782) (negative regulation of NMDA glutamate receptor activity), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008033](http://purl.obolibrary.org/obo/GO_0008033) (tRNA processing), [GO:1904783](http://purl.obolibrary.org/obo/GO_1904783) (positive regulation of NMDA glutamate receptor activity), [GO:1990180](http://purl.obolibrary.org/obo/GO_1990180) (mitochondrial tRNA 3'-end processing), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0022038](http://purl.obolibrary.org/obo/GO_0022038) (corpus callosum development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0106028](http://purl.obolibrary.org/obo/GO_0106028) (neuron projection retraction), [GO:0034414](http://purl.obolibrary.org/obo/GO_0034414) (tRNA 3'-trailer cleavage, endonucleolytic), [GO:0048170](http://purl.obolibrary.org/obo/GO_0048170) (positive regulation of long-term neuronal synaptic plasticity), [GO:2001275](http://purl.obolibrary.org/obo/GO_2001275) (positive regulation of glucose import in response to insulin stimulus), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0050771](http://purl.obolibrary.org/obo/GO_0050771) (negative regulation of axonogenesis), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0050770](http://purl.obolibrary.org/obo/GO_0050770) (regulation of axonogenesis), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0072684](http://purl.obolibrary.org/obo/GO_0072684) (mitochondrial tRNA 3'-trailer cleavage, endonucleolytic), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0045071](http://purl.obolibrary.org/obo/GO_0045071) (negative regulation of viral genome replication), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:1903078](http://purl.obolibrary.org/obo/GO_1903078) (positive regulation of protein localization to plasma membrane), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0042645](http://purl.obolibrary.org/obo/GO_0042645) (mitochondrial nucleoid), [GO:0048593](http://purl.obolibrary.org/obo/GO_0048593) (camera-type eye morphogenesis), [GO:0070373](http://purl.obolibrary.org/obo/GO_0070373) (negative regulation of ERK1 and ERK2 cascade), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.50%
- [GO:0099557](http://purl.obolibrary.org/obo/GO_0099557) (trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission) 51.67%
- [GO:0099545](http://purl.obolibrary.org/obo/GO_0099545) (trans-synaptic signaling by trans-synaptic complex) 51.67%
- [GO:0060997](http://purl.obolibrary.org/obo/GO_0060997) (dendritic spine morphogenesis) 51.67%
- [GO:0060996](http://purl.obolibrary.org/obo/GO_0060996) (dendritic spine development) 51.67%
- [GO:0048593](http://purl.obolibrary.org/obo/GO_0048593) (camera-type eye morphogenesis) 51.67%
- [GO:0022038](http://purl.obolibrary.org/obo/GO_0022038) (corpus callosum development) 51.67%
- [GO:0021631](http://purl.obolibrary.org/obo/GO_0021631) (optic nerve morphogenesis) 51.67%
- [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development) 51.67%
- [GO:0001655](http://purl.obolibrary.org/obo/GO_0001655) (urogenital system development) 51.67%
- [GO:0099545](http://purl.obolibrary.org/obo/GO_0099545) (trans-synaptic signaling by trans-synaptic complex) and [GO:0099550](http://purl.obolibrary.org/obo/GO_0099550) (trans-synaptic signaling, modulating synaptic transmission) 51.67%
- [GO:0099173](http://purl.obolibrary.org/obo/GO_0099173) (postsynapse organization) and [GO:0120039](http://purl.obolibrary.org/obo/GO_0120039) (plasma membrane bounded cell projection morphogenesis) 51.67%
- [GO:0097061](http://purl.obolibrary.org/obo/GO_0097061) (dendritic spine organization) and [GO:0120039](http://purl.obolibrary.org/obo/GO_0120039) (plasma membrane bounded cell projection morphogenesis) 51.67%
- [GO:0048869](http://purl.obolibrary.org/obo/GO_0048869) (cellular developmental process) and [GO:0099173](http://purl.obolibrary.org/obo/GO_0099173) (postsynapse organization) 51.67%
- [GO:0048869](http://purl.obolibrary.org/obo/GO_0048869) (cellular developmental process) and [GO:0097061](http://purl.obolibrary.org/obo/GO_0097061) (dendritic spine organization) 51.67%


